Abstract
Background
Intragastric balloon is a widely used technique to treat obesity that is considered to be more efficient than conservative treatment before bariatric surgery. To describe air-filled balloon (Heliosphere BAG®) effectiveness [absolute weight loss, body mass index (BMI) loss, percentage of body weight loss (BWL), percentage of excess weight loss (EWL)] and complications 6 months after its insertion.
Methods
Eighty-four consecutive intragastric balloons were placed endoscopically. Individualized nutritional counseling was given. The follow-up was carried out in an endocrinology outpatient clinic. Due to the weight or height data missed in two cases, only 82 patients were included in this report, 63 women with a mean age 39 years (SD, 11.1); mean BMI, 39.1 kg/m2 (SD, 5.8). The median follow-up was 182 days.
Results
The mean weight loss and BMI loss were 14.5 kg (SD, 8.2); and 5.3 kg/m2 (SD, 2.8), respectively (for difference, p < 0.001). The mean percentage of BWL was 13.4% (SD, 7.0). Of the sample, 70.4% achieved a percentage of BWL >10%. The percentage of EWL reached 33.2% (SD, 19.2). After adjusting by sex and initial BMI, absolute weight loss (p = 0.033), BMI loss (p = 0.034), percentage of BWL (p = 0.034), and percentage of EWL (p = 0.034) were inversely related to age. Absolute weight loss and BMI loss were greater in higher initial BMI, but the percentage of EWL was lower. Two spontaneous deflations occurred (3%), but only one surgical early removal (1.2%) was required. Nausea and vomiting developed in 7.4% of the patients during the first week.
Conclusions
Air-filled Heliosphere BAG® has been effective in achieving a relevant loss of body weight.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: WHO. 1998.
Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon Springs, Florida, March 19–21, 1987. Gastrointest Endosc. 1987;33:323–7.
Forestieri P, De Palma GD, Formato A, et al. Heliosphere Bag in the treatment of severe obesity: preliminary experience. Obes Surg. 2006;16:635–7.
Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicentre study. Obes Surg. 2007;17:764–9.
Allison C. Intragastric balloons: a temporary treatment for obesity. Issues Emerg Health Technol. 2006;79:1–4.
Trande P, Mussetto A, Mirante VG, et al. Efficacy, tolerance and safety of new intragastric air-filled balloon (Heliosphere BAG) for obesity: the experience of 17 cases. Obes Surg. 2010;20:1227–30.
Sciumè C, Geraci G, Pisello F, et al. Role of intragastric air-filled ballon (Heliosphere Bag) in severe obesity. Personal experience. Ann Ital Chir. 2009;80:113–7.
Imaz I, Martínez-Cervell C, García-Álvarez E, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.
Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.
Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. 2009;19:1084–8.
Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics® Intragastric Balloon (BIB®). Single ambulatory center spanish experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2010; (in press)
Doldi SB, Micheletto G, Perrini MN, et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg. 2002;12:583–7.
Doldi SB, Micheletto G, Di Prisco F, et al. Intragastric balloon in obese patients. Obes Surg. 2000;10:578–81.
Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8.
Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.
Frutos MD, Luján J, Hernández Q, et al. Results of laparoscopic gastric bypass in patients ≥ 55 years old. Obes Surg. 2006;16:461–4.
Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg. 2004;240:243–7.
St Peter SD, Craft RO, Tiede JL, et al. Impact of advanced age on weight loss and health benefits after laparoscopicgastric bypass. Arch Surg. 2005;140:165–8.
Nehoda H, Hourmont K, Sauper T, et al. Laparoscopic gastric banding in older patients. Arch Surg. 2001;136:1171–6.
Cossu ML, Fais E, Meloni GB, et al. Impact of age on long-term complications after biliopancreatic diversion. Obes Surg. 2004;14:1182–6.
Mazure R-A, Bretón I, Cáncer E, et al. Intragastric baloon in obesity treatment [in spanish]. Nutr Hosp. 2009;24:138–43.
Martinez-Brocca MA, Belda O, Parejo J, et al. Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity. Obes Surg. 2007;17:649–57.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lecumberri, E., Krekshi, W., Matía, P. et al. Effectiveness and Safety of Air-Filled Balloon Heliosphere BAG® in 82 Consecutive Obese Patients. OBES SURG 21, 1508–1512 (2011). https://doi.org/10.1007/s11695-010-0314-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-010-0314-9